Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Papamichail

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Cell|February 1, 1975
Lymphocyte: erythrocyte (L.E.) rosettes as indicators of the heterogeneity of lymphocytes in a variety of mammalian speciesC M Braganza, G Stathopoulos, A J Davies, et al.
British Journal of Cancer|April 17, 2003
Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cellsA D Gritzapis, A Mamalaki, A Kretsovali, et al.
Immunopharmacology and Immunotoxicology|January 1, 1990
Enhancement of human T lymphocyte function by prothymosin alpha: increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytesC N Baxevanis, S Frillingos, K Seferiadis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Granulocyte-macrophage colony-stimulating factor improves immunological parameters in patients with refractory solid tumours receiving second-line chemotherapy: correlation with clinical responsesC N Baxevanis, N B Tsavaris, S I Papadhimitriou, et al.
Immunopharmacology and Immunotoxicology|January 1, 1988
Mechanism of action of prothymosin alpha in the human autologous mixed lymphocyte responseC N Baxevanis, G J Reclos, M Economou, et al.
Immunology|April 1, 1978
The structural requirements for immunoglobulin aggregates to localize in germinal centresP H Embling, H Evans, C Guttierez, et al.
British Journal of Cancer|September 11, 2003
Cytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumoursP A Sotiropoulou, S A Perez, E G Iliopoulou, et al.
British Journal of Cancer|January 1, 1997
Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytesC N Baxevanis, M L Tsiatas, N T Cacoullos, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 1, 1995
Effect of testosterone administration, pre- and postnatally, on the immune system of ratsM M Konstadoulakis, K N Syrigos, C N Baxevanis, et al.
Journal of Neuroimmunology|March 1, 1989
Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosisC N Baxevanis, G J Reclos, C Servis, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Cell|February 1, 1975
Lymphocyte: erythrocyte (L.E.) rosettes as indicators of the heterogeneity of lymphocytes in a variety of mammalian speciesC M Braganza, G Stathopoulos, A J Davies, et al.
British Journal of Cancer|April 17, 2003
Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cellsA D Gritzapis, A Mamalaki, A Kretsovali, et al.
Immunopharmacology and Immunotoxicology|January 1, 1990
Enhancement of human T lymphocyte function by prothymosin alpha: increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytesC N Baxevanis, S Frillingos, K Seferiadis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Granulocyte-macrophage colony-stimulating factor improves immunological parameters in patients with refractory solid tumours receiving second-line chemotherapy: correlation with clinical responsesC N Baxevanis, N B Tsavaris, S I Papadhimitriou, et al.
Immunopharmacology and Immunotoxicology|January 1, 1988
Mechanism of action of prothymosin alpha in the human autologous mixed lymphocyte responseC N Baxevanis, G J Reclos, M Economou, et al.
Immunology|April 1, 1978
The structural requirements for immunoglobulin aggregates to localize in germinal centresP H Embling, H Evans, C Guttierez, et al.
British Journal of Cancer|September 11, 2003
Cytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumoursP A Sotiropoulou, S A Perez, E G Iliopoulou, et al.
British Journal of Cancer|January 1, 1997
Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytesC N Baxevanis, M L Tsiatas, N T Cacoullos, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 1, 1995
Effect of testosterone administration, pre- and postnatally, on the immune system of ratsM M Konstadoulakis, K N Syrigos, C N Baxevanis, et al.
Journal of Neuroimmunology|March 1, 1989
Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosisC N Baxevanis, G J Reclos, C Servis, et al.
Pageof 12